THE ULTIMATE GUIDE TO LDN-27219 AS A CANCER DRUG CANDIDATE

Consensus sequence for tTG crosslinking substrates. Alignment of all glutamine-donor crosslinking substrates described within the Transdab databases demonstrates that in addition to glutamine (Q at posture 0), there is small to no favoritism for different residues at up to 5 positions ahead of or after the glutamine residue to become crosslinked. D